Skip to main content
Erschienen in: World Journal of Surgery 12/2017

31.07.2017 | Original Scientific Report

Pheochromocytoma with Synchronous Ipsilateral Adrenal Cortical Adenoma

verfasst von: M. Earth Hasassri, T. K. Pandian, Aleh A. Bobr, Irina Bancos, William F. Young Jr., Melanie L. Richards, David R. Farley, Geoffrey B. Thompson, Travis J. McKenzie

Erschienen in: World Journal of Surgery | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Pheochromocytoma with synchronous ipsilateral adrenal cortical adenoma (PSCA) may present with mixed clinical, biochemical, and radiological features characteristic to each neoplasm subtype.

Methods

All patients with a pathological diagnosis of pheochromocytoma were evaluated for an ipsilateral cortical adenoma from 1994 through 2015. Retrospectively extracted data included indications for adrenalectomy, diagnostic workup (biochemical and radiographic), operative characteristics, pathological findings, and postoperative complications.

Results

Sixteen of 413 patients (4%) undergoing adrenalectomy for pheochromocytoma had a PSCA. Median patient age was 57.7 years (IQR 50.1, 63.1); 50% were male. On imaging, 75% of the adrenal neoplasms were found incidentally and only 50% were reported to have a synchronous ipsilateral neoplasm based on imaging findings. Clinically important cortical hormone secretion was diagnosed in 38% of these patients; 25% had glucocorticoid secretory autonomy; and 13% had primary aldosteronism.

Conclusion

Physicians should be aware that adrenal neoplasms with mixed diagnostic findings may represent PSCA. Evaluation should be performed on this co-occurrence to prevent perioperative complications from resection of an unexpected secretory cortical neoplasm.
Literatur
1.
Zurück zum Zitat Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM (1991) Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110(6):1014–1021PubMed Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM (1991) Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110(6):1014–1021PubMed
3.
Zurück zum Zitat Bernini GP, Moretti A, Mannelli M, Ercolino T, Bardini M, Caramella D et al (2005) Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene. J Endocrinol Invest 28(11):1032–1037CrossRefPubMed Bernini GP, Moretti A, Mannelli M, Ercolino T, Bardini M, Caramella D et al (2005) Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene. J Endocrinol Invest 28(11):1032–1037CrossRefPubMed
4.
Zurück zum Zitat Cope O, Labbe JP, Raker JW, Bland EF (1952) Pheochromocytoma and adrenal cortical adenoma; report of a case with both tumors and discussion of their relation. J Clin Endocrinol Metab 12(7):875–880CrossRefPubMed Cope O, Labbe JP, Raker JW, Bland EF (1952) Pheochromocytoma and adrenal cortical adenoma; report of a case with both tumors and discussion of their relation. J Clin Endocrinol Metab 12(7):875–880CrossRefPubMed
5.
Zurück zum Zitat Hwang WR, Ma WY, Tso AL, Pan CC, Chang YH, Lin HD (2007) Pheochromocytoma and adrenocortical adenoma in the same gland. J Chin Med Assoc JCMA 70(7):289–293CrossRefPubMed Hwang WR, Ma WY, Tso AL, Pan CC, Chang YH, Lin HD (2007) Pheochromocytoma and adrenocortical adenoma in the same gland. J Chin Med Assoc JCMA 70(7):289–293CrossRefPubMed
6.
Zurück zum Zitat Inoue J, Oishi S, Naomi S, Umeda T, Sato T (1986) Pheochromocytoma associated with adrenocortical adenoma: case report and literature review. Endocrinol Jpn 33(1):67–74CrossRefPubMed Inoue J, Oishi S, Naomi S, Umeda T, Sato T (1986) Pheochromocytoma associated with adrenocortical adenoma: case report and literature review. Endocrinol Jpn 33(1):67–74CrossRefPubMed
7.
Zurück zum Zitat Miyazawa K, Kigoshi T, Nakano S, Kobayashi Y, Suzuki K, Tsugawa R et al (1998) Hypertension due to coexisting pheochromocytoma and aldosterone-producing adrenal cortical adenoma. Am J Nephrol 18(6):547–550CrossRefPubMed Miyazawa K, Kigoshi T, Nakano S, Kobayashi Y, Suzuki K, Tsugawa R et al (1998) Hypertension due to coexisting pheochromocytoma and aldosterone-producing adrenal cortical adenoma. Am J Nephrol 18(6):547–550CrossRefPubMed
8.
Zurück zum Zitat Sakamoto N, Tojo K, Saito T, Fujimoto K, Isaka T, Tajima N et al (2009) Coexistence of aldosterone-producing adrenocortical adenoma and pheochromocytoma in an ipsilateral adrenal gland. Endocr J 56(2):213–219CrossRefPubMed Sakamoto N, Tojo K, Saito T, Fujimoto K, Isaka T, Tajima N et al (2009) Coexistence of aldosterone-producing adrenocortical adenoma and pheochromocytoma in an ipsilateral adrenal gland. Endocr J 56(2):213–219CrossRefPubMed
9.
Zurück zum Zitat Sato H, Igarashi H, Kishimoto Y, Yamaguchi K, Saito T, Ishida H et al (2002) Combined tumor consisting of non-functioning adrenocortical adenoma and pheochromocytoma in the same gland. Int J Urol 9(7):398–401CrossRefPubMed Sato H, Igarashi H, Kishimoto Y, Yamaguchi K, Saito T, Ishida H et al (2002) Combined tumor consisting of non-functioning adrenocortical adenoma and pheochromocytoma in the same gland. Int J Urol 9(7):398–401CrossRefPubMed
10.
Zurück zum Zitat Sparagana M, Feldman JM, Molnar Z (1987) An unusual pheochromocytoma associated with an androgen secreting adrenocortical adenoma. Evaluation of its polypeptide hormone, catecholamine, and enzyme characteristics. Cancer 60(2):223–231CrossRefPubMed Sparagana M, Feldman JM, Molnar Z (1987) An unusual pheochromocytoma associated with an androgen secreting adrenocortical adenoma. Evaluation of its polypeptide hormone, catecholamine, and enzyme characteristics. Cancer 60(2):223–231CrossRefPubMed
11.
Zurück zum Zitat Yotsuyanagi S, Fuse H, Koshida K, Uchibayashi T, Namiki M (2001) A case of adrenal pheochromocytoma with contralateral adrenocortical adenoma. Hinyokika Kiyo 47(2):89–93PubMed Yotsuyanagi S, Fuse H, Koshida K, Uchibayashi T, Namiki M (2001) A case of adrenal pheochromocytoma with contralateral adrenocortical adenoma. Hinyokika Kiyo 47(2):89–93PubMed
12.
Zurück zum Zitat Aiba M, Hirayama A, Ito Y, Fujimoto Y, Nakagami Y, Demura H et al (1988) A compound adrenal medullary tumor (pheochromocytoma and ganglioneuroma) and a cortical adenoma in the ipsilateral adrenal gland. A case report with enzyme histochemical and immunohistochemical studies. Am J Surg Pathol 12(7):559–566CrossRefPubMed Aiba M, Hirayama A, Ito Y, Fujimoto Y, Nakagami Y, Demura H et al (1988) A compound adrenal medullary tumor (pheochromocytoma and ganglioneuroma) and a cortical adenoma in the ipsilateral adrenal gland. A case report with enzyme histochemical and immunohistochemical studies. Am J Surg Pathol 12(7):559–566CrossRefPubMed
13.
Zurück zum Zitat Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A et al (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian society of endocrinology. J Clin Endocrinol Metab 85(2):637–644. doi:10.1210/jcem.85.2.6372 PubMed Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A et al (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian society of endocrinology. J Clin Endocrinol Metab 85(2):637–644. doi:10.​1210/​jcem.​85.​2.​6372 PubMed
14.
Zurück zum Zitat Cawood TJ, Hunt PJ, O’Shea D, Cole D, Soule S (2009) Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol 161(4):513–527CrossRefPubMed Cawood TJ, Hunt PJ, O’Shea D, Cole D, Soule S (2009) Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol 161(4):513–527CrossRefPubMed
15.
Zurück zum Zitat Barrett C, van Uum SHM, Lenders JWM (2015) Risk of catecholaminergic crisis following glucocorticoid administration in patients with an adrenal mass: a literature review. Clin Endocrinol (Oxf) 83(5):622–628CrossRef Barrett C, van Uum SHM, Lenders JWM (2015) Risk of catecholaminergic crisis following glucocorticoid administration in patients with an adrenal mass: a literature review. Clin Endocrinol (Oxf) 83(5):622–628CrossRef
16.
Zurück zum Zitat Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS et al (2005) Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: cleveland clinic experience. J Clin Endocrinol Metab 90(2):871–877. doi:10.1210/jc.2004-1627 CrossRefPubMed Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS et al (2005) Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: cleveland clinic experience. J Clin Endocrinol Metab 90(2):871–877. doi:10.​1210/​jc.​2004-1627 CrossRefPubMed
18.
Zurück zum Zitat Constantinides VA, Christakis I, Touska P, Palazzo FF (2012) Systematic review and meta-analysis of retroperitoneoscopic versus laparoscopic adrenalectomy. Br J Surg 99(12):1639–1648CrossRefPubMed Constantinides VA, Christakis I, Touska P, Palazzo FF (2012) Systematic review and meta-analysis of retroperitoneoscopic versus laparoscopic adrenalectomy. Br J Surg 99(12):1639–1648CrossRefPubMed
19.
Zurück zum Zitat Lenders JWM, Duh Q-Y, Eisenhofer G, Gimenez-Roqueplo A-P, Grebe SKG, Murad MH et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915–1942CrossRefPubMed Lenders JWM, Duh Q-Y, Eisenhofer G, Gimenez-Roqueplo A-P, Grebe SKG, Murad MH et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915–1942CrossRefPubMed
20.
Zurück zum Zitat Reid IA, Schrier RW, Earley LE (1972) An effect of extrarenal beta adrenergic stimulation on the release of renin. J Clin Invest 51(7):1861–1869CrossRefPubMedPubMedCentral Reid IA, Schrier RW, Earley LE (1972) An effect of extrarenal beta adrenergic stimulation on the release of renin. J Clin Invest 51(7):1861–1869CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Hsieh BS, Chen FW, Hsu HC, Chang CC, Chen WY (1979) Hyperaldosteronism with coexistence of adrenal cortical adenoma and pheochromocytoma. Taiwan Yi Xue Hui Za Zhi 78(5):445–451 Hsieh BS, Chen FW, Hsu HC, Chang CC, Chen WY (1979) Hyperaldosteronism with coexistence of adrenal cortical adenoma and pheochromocytoma. Taiwan Yi Xue Hui Za Zhi 78(5):445–451
22.
Zurück zum Zitat Sakuma I, Higuchi S, Fujimoto M, Takiguchi T, Nakayama A, Tamura A et al (2016) Cushing syndrome due to ACTH-Secreting pheochromocytoma, aggravated by glucocorticoid-driven positive-feedback loop. J Clin Endocrinol Metab 101(3):841–846CrossRefPubMed Sakuma I, Higuchi S, Fujimoto M, Takiguchi T, Nakayama A, Tamura A et al (2016) Cushing syndrome due to ACTH-Secreting pheochromocytoma, aggravated by glucocorticoid-driven positive-feedback loop. J Clin Endocrinol Metab 101(3):841–846CrossRefPubMed
23.
Zurück zum Zitat Neri G, Andreis PG, Prayer-Galetti T, Rossi GP, Malendowicz LK, Nussdorfer GG (1996) Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab 81(1):169–173PubMed Neri G, Andreis PG, Prayer-Galetti T, Rossi GP, Malendowicz LK, Nussdorfer GG (1996) Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab 81(1):169–173PubMed
24.
Zurück zum Zitat Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, Eisenhofer G (2008) Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol 158(3):423–429CrossRefPubMed Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, Eisenhofer G (2008) Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol 158(3):423–429CrossRefPubMed
Metadaten
Titel
Pheochromocytoma with Synchronous Ipsilateral Adrenal Cortical Adenoma
verfasst von
M. Earth Hasassri
T. K. Pandian
Aleh A. Bobr
Irina Bancos
William F. Young Jr.
Melanie L. Richards
David R. Farley
Geoffrey B. Thompson
Travis J. McKenzie
Publikationsdatum
31.07.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 12/2017
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4110-8

Weitere Artikel der Ausgabe 12/2017

World Journal of Surgery 12/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.